-
National MS Society Invests $330,000 in Antibody Therapy
Fast Forward, an arm of the National Multiple Sclerosis Society, is investing up to $330,000 to advance the clinical development of an antibody. Read more about this investment here.
What do you think about this research investment?
Sorry, there were no replies found.
Log in to reply.